What Is a Biotinylated Peptide?

What biotinylation is used for

Biotin is a small vitamin that binds streptavidin and avidin with very high affinity. Attaching it to a peptide gives the peptide a molecular handle that can be captured, detected or immobilized without changing the peptide's own sequence.

The main applications follow from that handle. A biotinylated peptide can be immobilized on a streptavidin-coated plate for a binding assay, captured from a mixture for pull-down experiments, detected on a blot with an enzyme-labelled streptavidin, or tethered to a surface at a controlled density. Because the interaction is essentially irreversible under normal conditions, capture is efficient and washing can be stringent.

Biotinylation is therefore a labelling modification rather than a stability modification. It does not usually change the peptide's half-life or protease sensitivity, although a bulky biotin near a binding site can change activity. The design question is where to put it so that streptavidin can reach it without blocking the interaction being studied.

Where biotin is attached: N-terminus, lysine and cysteine

The N-terminus is the easiest site in solid-phase synthesis because the biotin can be coupled as the final residue before cleavage. A lysine side chain is equally accessible but requires the other lysines to be protected or absent, otherwise the product is a mixture. A cysteine handle is the most selective option in solution and is often introduced solely to carry the label.

For a peptide that already contains a critical lysine in its binding site, biotinylation at that lysine will probably destroy activity. Moving the label to the N-terminus or to an added cysteine avoids the problem.

Why a spacer matters: biotin versus biotin-ahx

Biotin is a small group, and streptavidin is a large tetramer. When biotin sits directly on the peptide surface, the streptavidin can clash with neighbouring residues and bind poorly even though the biotin itself is intact. A spacer moves the biotin away from the peptide and into the streptavidin pocket.

Biotin-ahx adds a 6-aminohexanoic acid linker, roughly 7–8 atoms long, between the peptide and the biotin. It is the form most suppliers recommend for capture and detection because it improves access without adding much flexibility or hydrophobicity. Longer PEG spacers are used when the peptide is large or when the surface is crowded.

The choice affects the mass shift and the chromatography. Biotin alone adds about 226 Da; biotin-ahx adds about 340 Da. Both are hydrophobic and can shift retention time, so the labelled peptide should be run against the unlabelled parent during method development.

The streptavidin-biotin interaction and its limits

Streptavidin binds biotin with an affinity in the femtomolar range, among the strongest non-covalent interactions known. That is why capture works at low peptide concentrations and why washing can be harsh. It is also why the bond is effectively irreversible: eluting a captured biotinylated peptide usually requires denaturing conditions, biotin competition or cleavage of a linker.

Avidin behaves similarly but is glycosylated and positively charged at neutral pH, which causes non-specific binding to acidic surfaces. Neutravidin is a deglycosylated, near-neutral variant that reduces that background. For most assays, streptavidin or neutravidin is the better choice.

Endogenous biotin is a common source of background in tissue and cell lysates. Blocking with free biotin or using a biotin-free blocking reagent is often necessary. The problem is not the peptide but the sample, and it should be planned for before the assay is run.

Pitfalls: steric hindrance, multiple labelling and lost binding

Steric hindrance. A biotin placed at or near the receptor contact surface can block binding. The same biotin moved one or two residues away may be silent. If activity drops after labelling, the first experiment is to compare the labelled and unlabelled peptides in the same assay.

Multiple labelling. A peptide with three lysines can carry one, two or three biotins. Multi-labelled species may bind several streptavidins, which cross-links the peptide and changes its behaviour. Site-specific chemistry or an added cysteine avoids the mixture.

Loss of solubility. Biotin and ahx are hydrophobic enough to reduce the solubility of an already marginal peptide. If the product clouds at the working concentration, a charged spacer or a different site may solve it. Peptide solubility sets out the handling options.

Reversed orientation. When a biotinylated peptide is captured on a surface, the peptide is presented tethered at the labelled end. That orientation may hide the epitope. Placing biotin at the opposite terminus can restore recognition.

How a biotinylated peptide is analysed

Mass spectrometry is the primary check. The observed mass should match the calculated peptide mass plus 226.08 Da for biotin or 340.20 Da for biotin-ahx. A peak at the unlabelled mass means incomplete labelling; a peak at twice the shift means two labels.

HPLC confirms purity and shows the expected retention shift. Biotinylated peptides usually elute later than their parents on a C18 column because the biotin is hydrophobic. A broad or split peak can indicate a mixture of labelling states.

A functional check is often more informative than either. Binding to streptavidin-coated plates, capture on beads, or a blot with labelled streptavidin confirms that the biotin is accessible. A peptide that passes mass spectrometry but fails capture usually has a steric problem, not a synthetic one. Our peptide testing services cover both the analytical and the functional checks.

What to specify on a biotinylated peptide order

State the sequence, the exact attachment site, and whether the biotin should be free or on an ahx spacer. If a cysteine is to carry the label, confirm that the sequence has the right number of cysteines and whether any are needed for a disulfide. If the peptide will be captured on a surface, say so, because orientation may determine which terminus should carry the biotin.

Ask for the mass shift to be stated on the certificate of analysis. That single number resolves most questions about labelling state, and it makes batch-to-batch comparison straightforward.

MOL Changes performs biotinylation as part of its peptide biotinylation service, using the same HPLC and LC-MS release testing described in purity testing.